AMA CPT® Assistant - 2023 Issue 3 (March)
New COVID-19 Vaccine Codes: March Update (March Special Update 2023)
March Special Update 2023 page 1 New COVID-19 Vaccine Codes: March Update The Current Procedural Terminology (CPT®) Editorial Panel (the Panel) has approved a new vaccine administration code (0174A) for the administration of a booster dose of the Pfizer bivalent vaccine product to address severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) for patients aged 6 months through 4 years. This code will become effective upon receiving emergency use authorization (EUA) from the Food and Drug Administration (FDA). In order to assist CPT code users in differentiating and reporting the available vaccine product codes and their...
Subscribe or sign in to view the full article.
Article Overview
This CPT Assistant special update reviews a March 2023 COVID-19 vaccine coding change, including new and revised immunization administration guidance, related appendix updates, and context for pediatric Pfizer bivalent vaccine reporting. It is relevant to coders, billers, compliance staff, and clinical documentation teams working with CPT vaccine administration and COVID-19 immunization records.
Why This Topic Matters
COVID-19 vaccine coding changed frequently during the public health emergency, and this update helps readers understand the latest CPT panel action, the associated appendix structure, and the general scope of reporting guidance for affected pediatric patients.
Article Sections
-
March Special Update 2023 page 1
Introduces the March 2023 CPT Assistant special update and frames the article’s focus on COVID-19 vaccine coding changes and related guidance.
-
Immunization Administration for Vaccines/Toxoids
Covers the vaccine administration guidance discussed in the update, including the affected CPT coding structure and the general context for reporting updates.
-
Table 1 Excerpt from Appendix Q: New Pfizer Bivalent COVID-19 Vaccine Product and Vaccine Administration Codes
Presents an appendix excerpt summarizing the vaccine product and associated administration code information referenced in the article.
-
Clinical Example (0174A)
Provides a brief clinical scenario illustrating the kind of patient situation addressed by the new guidance.
-
Description of Procedure (0174A)
Summarizes the general procedural workflow associated with the clinical example, including documentation and visit-related activities.
What You Will Learn
- What the March 2023 CPT update addresses in relation to COVID-19 vaccine administration coding
- Which broad vaccine administration and appendix resources are discussed
- How the article frames pediatric Pfizer bivalent booster reporting guidance
- What types of supporting examples and procedural context are included
Who Should Read This
- Medical coders
- Medical billers
- Compliance professionals
- Healthcare documentation specialists
- Clinical staff involved in immunization workflows
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com
